United Therapeutics Insider Sold Shares Worth $5,215,015, According to a Recent SEC Filing

MT newswire2026/10/08 21:33

05:33 PM EDT, 10/08/2026 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & CEO, on October 07, 2026, sold 9,500 shares in United Therapeutics (UTHR) for $5,215,015. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 668,728 common shares of the company, with 40,513 shares held directly and 628,215 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1082554/000110657826000159/xslF345X05/primarydocument.xml

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.